# A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity

> **NCT07665879** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 115 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** Eloralintide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07665879
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665879, "A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*